BBMRI-ERIC.EU

Publications

Bouchal, P., Dvořáková, M., Roumeliotis, T., Bortlíček, Z., Ihnatová, I., Procházková, I., Ho, J.T.C., Maryáš, J., Imrichová, H., Budinská, E., Vyzula, R., Garbis, S.D., Vojtěšek, B., Nenutil, R. Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer. Mol Cell Proteomics 2015;14(7):1814-1830. (IF: 6.564).
Cizkova, M.Susini, A., Vacher, S., Cizeron-Clairac, G., Andrieu, C., Driouch, K., Fourme, E., Lidereau R., Biéche, A.I. Pik3ca mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups. Breast Cancer Research. 2012, 14(1): R28. (IF: 5.245).

Cizkova, M., Dujaric, M.-E., Lehmann-Che, J., Scott, V., Tembo, O., Asselain, B., Pierga, J.Y., Marty, M., de Cremoux, P., Spyratos, F., Biéche, A.I. Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab. British Journal of Cancer. 2013;108(9):1807-1809. (IF: 5.082).
Janeckova, H., Hron, K., Wojtowicz, P., Hlidkova, E., Baresova, A., Friedecky, D., Zidkova, L., Hornik, P., Behulova, D., Prochazkova, D., Vinohradska, H., Peskova, K., Bruheim, P., Smolka, V., Stastna, S., Adam, A.T. Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders. Journal of Chromatography A. 2012;1226(-):11-17. (IF: 4.194).

Němejcová, K., Kenny, S.L., Laco, J., Škapa, P., Staněk, L., Zikán, M., Kleiblová, P., McCluggage, W.G., Dundr, P. Atypical Polypoid Adenomyoma of the Uterus: An Immunohistochemical and Molecular Study of 21 Cases. Am J Surg Pathol 2015;39(8):1148-55.(IF: 4.9).

Oplustilova, L., Wolanin, K., Mistrik, M., Korinkova, G., Simkova, D., Bouchal, J., Lenobel, R., Bartkova, J., Lau, A., O´Connor, M.J., Lukas, J., Bartek, J. Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment. Cell Cycle. 2012;11(20):3837-3805. (IF: 5.321).

Ryška, A. Molecular pathology in real time. Cancer Metastasis Rev 2016;35(1):129-140. (IF: 5,316).

Sevcik, J., Falk, M., Macurek, L., Kleiblova, P., Lhota, F., Hojny, J., Stefancikova, L., Janatova, M., Bartek, J., Stribrna, J., Hodny, Z., Jezkova, L., Pohlreich, P. Kleibl Z. Expression of human BRCA1Δ17-19 alternative splicing variant with a truncated BRCT domain in MCF-7 cells results in impaired assembly of DNA repair complexes and aberrant DNA damage response. Cellular Signalling. 2013;25(5):1186-1193. (IF:4.304).

Vašatová, M., Pudil, R., Horáček, J., Büchler, T. Current Applications of Cardiac Troponin T for the Diagnosis of Myocardial Damage. Advances in Clinical Chemistry. 2013;61:33-65. (IF: 4.302).

Ranc, V., Srovnal, J., Kvitek L., Hajdúch, M. Discrimination of circulating tumor cells of breast cancer and colorectal cancer from normal human mononuclear cells using Raman spectroscopy. Analyst. 2013;138(20):5983-5988. (IF: 3.969)

Patents

ETH Zurich; Palacky University, Olomouc. Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer. Inventor: SURINOVA, S., R. AEBERSOLD, M. HAJDUCH, J. SROVNAL, J. DRABEK a L. RADOVA. WIPO. Patent application, WO 2013152989 A2. 2013-10-17.

Palacky University, Olomouc; Institute of Animal Physiology and Genetics ASCR, v.v.i. Libechov. Method of determination of cancer cell drug sensitivity towards Aurora kinase inhibitors and overcoming their resistance. Inventor: KOLLAREDDY, M.R., M. HAJDUCH, P. DZUBAK, J. SROVNAL, R. HRABAKOVA a H. KOVAROVA. EPO. Patent application, EP 2602330 A1. 2013-06-12.

Mrkvicová, M., Valík, D., Zdražilová Dubská L. Stanovení mutací v genu TPMT: detekce na základě mutačně specifické real-time PCR. 2014. N/A - Uplatněná certifikovaná metodika. RIV/00209805:_____/14:#0000497.

Palacky University, Olomouc; Institute of Animal Physiology and Genetics ASCR, v.v.i. Method of determination of cancer cell drug sensitivity towards Aurora kinase inhibitors. Vynálezce: KOLLAREDDY, M. R., M. HAJDUCH, P. DZUBAK, J. SROVNAL, R. HRABAKOVA a H. KOVAROVA. EPO. Patentový spis, EP 2788504 B1. 2016-08-17.

Palacky University, Olomouc. Sample containters, Inventor: DŽUBÁK, P. a M. HAJDÚCH. EUIPO. Utility pattern, RCD 003039577-0001, 2016-03-23.

Palacky University, Olomouc. Culturing kit for microscopy of adhesively growing cell structures. Inventors: MISTRÍK M. a J. BÁRTEK.Utility pattern. CZ 29265, 2016-03-15.

Palacky University, Olomouc. Mobile hyperbaric miniature chambre. Inventor: KOLÁŘOVÁ H., BAJGAR R., TOMÁNKOVÁ K., BOLEK L., DEJMEK J., BOLEK M., RŮŽIČKA J. a J. BENEŠ. Patent application, CZ 305989, 2016-04-27.

Palacky University, Olomouc. Stand for magnetic separation of ferromagnetic Inventor: KOBERNA K. a A. LIGASOVÁ. Industrial pattern, CZ 36681, 2016-03-02.

Palacky University, Olomouc. Device for magnetic separation of ferromagnetic particles, kit for magnetic separation of the particles, method of separation of magnetic particles from a solution and use thereof. Inventor: KOBERNA K. a A. LIGASOVÁ. Patent application, CZ 306187, 2016-08-03.

Projects

LM2010004: BBMRI-CZ in the building of the Czech part of a large distributed research infrastructure of pan-European importance: the creation and operation of the network of banks of biological material for biomedical research,
LM2011024: EATRIS-CZ (Enhancement and Connection of the Czech Translational Medicine Infrastructures to the European Advanced Translational Medicine Infrastructure),
LM2015089: Bank of Clinical Ministry of Education, Youth and Sports.
IGA MH CR NT/13549-4/2012: Vytvoření diagnostické sady cirkulujících mikroRNA pro neinvazivní časnou diagnostiku a sledování pacientů s kolorektálním karcinomem. Ondřej Slabý, Ph.D.
MEYS MSM0021620808: Research plan and follow up research of ovarian cancer - First Faculty of Medicine, Charles University in Prague. Luděk Záveský, Ph.D.
OP R&D pI CZ.1.05/2.1.00/03.0101: Regional Centre for Applied Molecular Oncology. Doc. MUDr. Dalibor Valík, Ph.D.
P206/12/G151: Center of novel approaches to bioanalysis and molecular diagnostics. RNDr. Bořivoj Vojtěšek, DrSc.
GAČR 13-00956S: Emerging roles for the proteins of Anterior Gradient family in cancer development.Roman Hrstka, Ph.D.
GAČR 14-24931P: Electrochemical methods for bioanalysis of nucleic acids and their application in cancer diagnostics. Mgr. Martin Bartošík, Ph.D.
GAČR 16-04496S: Glycobiological investigations pertaining to biomolecular differentiation of mammary carcinomas. prof. RNDr. Miloš Novotný DrSc.
GAČR 14-19250S: A novel panel of proteins associated with lymph node status in low-grade breast cancer: Clinical verification and role in tumor cell invasiveness. Mgr. Pavel Bouchal, Ph.D.
IGA MH CZ NT14602-3-2013: p63 and p73 proteins as predictive markers in clinical oncology. Mgr. Jitka Holčáková, Ph.D.
IGA MH CR NT/13794-4/2012: The analysis of chaperone system and identification of new biomarkers associated with gynecological malignancies. RNDr. Bořivoj Vojtěšek, DrSc.
GAČR 301/10/1615: AGR2 protein family: implication for cancer biology. Mgr. Roman Hrstka, Ph.D.
Grant project NT 14150-3/2013: Ovlivnění kolorektálního karcinomu biologickou léčbou - in vitro studie. Prof. MUDr. Aleš Ryška, Ph.D.
Tissue engineering of genetically competent corneal/conjunctival cells for subsequent grafting in human medicine, Czech-Norwegian Research Program, Ministry of Education, Youth and Sports, MSMT-28477/2014, project: 7F14156 (BBMRI participates on retrieval and storage of eye tissue for research.
INFLA-CARE – Understanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies. (7. FP)
A/CZ0046/1/0022 - Research of new compounds as potential drugs against childhood cancers (EEA grants/Norway grants)
Enhancement of Research Infrastructure for Individualised Therapy of Chronically Sick Children (EEA grants/Norway grants)
676550: ADOPT BBMRI-ERIC (implementation and operation of the gateway for health into BBMRI-ERIC).
654142: EGI-ENGAGE (Engaging the EGI Community towards an Open Science Commons)